These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
111 related articles for article (PubMed ID: 22716243)
1. In vitro research on vitiligo: strategies, principles, methodological options and common pitfalls. Dell'anna ML; Cario-André M; Bellei B; Taieb A; Picardo M Exp Dermatol; 2012 Jul; 21(7):490-6. PubMed ID: 22716243 [TBL] [Abstract][Full Text] [Related]
2. Melanocytes are not absent in lesional skin of long duration vitiligo. Tobin DJ; Swanson NN; Pittelkow MR; Peters EM; Schallreuter KU J Pathol; 2000 Aug; 191(4):407-16. PubMed ID: 10918216 [TBL] [Abstract][Full Text] [Related]
4. Epidermal reconstructs in vitiligo: an extrinsic factor is needed to trigger the disease. Bessou S; Gauthier Y; Surlève-Bazeille JE; Pain C; Taïeb A Br J Dermatol; 1997 Dec; 137(6):890-7. PubMed ID: 9470904 [TBL] [Abstract][Full Text] [Related]
5. RNA released from necrotic keratinocytes upregulates intercellular adhesion molecule-1 expression in melanocytes. Zhang S; Liu S; Yu N; Xiang L Arch Dermatol Res; 2011 Dec; 303(10):771-6. PubMed ID: 21877251 [TBL] [Abstract][Full Text] [Related]
6. FK506 promotes melanocyte and melanoblast growth and creates a favourable milieu for cell migration via keratinocytes: possible mechanisms of how tacrolimus ointment induces repigmentation in patients with vitiligo. Lan CC; Chen GS; Chiou MH; Wu CS; Chang CH; Yu HS Br J Dermatol; 2005 Sep; 153(3):498-505. PubMed ID: 16120133 [TBL] [Abstract][Full Text] [Related]
7. Ultrastructural and functional alterations of mitochondria in perilesional vitiligo skin. Prignano F; Pescitelli L; Becatti M; Di Gennaro P; Fiorillo C; Taddei N; Lotti T J Dermatol Sci; 2009 Jun; 54(3):157-67. PubMed ID: 19282153 [TBL] [Abstract][Full Text] [Related]
8. Immunolocalization of tenascin-C in vitiligo. Abdou AG; Maraee AH; Shoeib MA; Elbana R Appl Immunohistochem Mol Morphol; 2012 Oct; 20(5):501-11. PubMed ID: 22495383 [TBL] [Abstract][Full Text] [Related]
9. Effect of PUVA therapy on melanocytes and keratinocytes in non-segmental vitiligo: histopathological, immuno-histochemical and ultrastructural study. Anbar TS; El-Sawy AE; Attia SK; Barakat MT; Moftah NH; El-Ammawy TS; Abdel-Rahman AT; El-Tonsy MH Photodermatol Photoimmunol Photomed; 2012 Feb; 28(1):17-25. PubMed ID: 22211999 [TBL] [Abstract][Full Text] [Related]
10. Histamine effect on melanocyte proliferation and vitiliginous keratinocyte survival. Kim NH; Lee AY Exp Dermatol; 2010 Dec; 19(12):1073-9. PubMed ID: 21054556 [TBL] [Abstract][Full Text] [Related]
11. The melanocytorrhagic hypothesis of vitiligo tested on pigmented, stressed, reconstructed epidermis. Cario-André M; Pain C; Gauthier Y; Taïeb A Pigment Cell Res; 2007 Oct; 20(5):385-93. PubMed ID: 17850512 [TBL] [Abstract][Full Text] [Related]
12. Low-energy helium-neon laser induces melanocyte proliferation via interaction with type IV collagen: visible light as a therapeutic option for vitiligo. Lan CC; Wu CS; Chiou MH; Chiang TY; Yu HS Br J Dermatol; 2009 Aug; 161(2):273-80. PubMed ID: 19438447 [TBL] [Abstract][Full Text] [Related]
13. The mRNA expression profile of cytokines connected to the regulation of melanocyte functioning in vitiligo skin biopsy samples and peripheral blood mononuclear cells. Reimann E; Kingo K; Karelson M; Reemann P; Loite U; Sulakatko H; Keermann M; Raud K; Abram K; Vasar E; Silm H; Kõks S Hum Immunol; 2012 Apr; 73(4):393-8. PubMed ID: 22333690 [TBL] [Abstract][Full Text] [Related]
14. Vitiligo: where do we stand? Ortonne JP; Bose SK Pigment Cell Res; 1993 Mar; 6(2):61-72. PubMed ID: 8321867 [TBL] [Abstract][Full Text] [Related]
15. Aberrant Notch signaling: a potential pathomechanism of vitiligo. Diao JS; Zhang X; Xia WS; Zheng Y; Ren J; Wang YM; Gong Z; Xia W; Guo SZ Med Hypotheses; 2009 Jul; 73(1):70-2. PubMed ID: 19269111 [TBL] [Abstract][Full Text] [Related]
16. Altered levels of Ets-1 transcription factor and matrix metalloproteinases in melanocytes from patients with vitiligo. Kumar R; Parsad D; Kanwar AJ; Kaul D Br J Dermatol; 2011 Aug; 165(2):285-91. PubMed ID: 21428970 [TBL] [Abstract][Full Text] [Related]
17. Transcriptome analysis reveals markers of aberrantly activated innate immunity in vitiligo lesional and non-lesional skin. Yu R; Broady R; Huang Y; Wang Y; Yu J; Gao M; Levings M; Wei S; Zhang S; Xu A; Su M; Dutz J; Zhang X; Zhou Y PLoS One; 2012; 7(12):e51040. PubMed ID: 23251420 [TBL] [Abstract][Full Text] [Related]
18. Keratinocyte cultures from involved skin in vitiligo patients show an impaired in vitro behaviour. Bondanza S; Maurelli R; Paterna P; Migliore E; Giacomo FD; Primavera G; Paionni E; Dellambra E; Guerra L Pigment Cell Res; 2007 Aug; 20(4):288-300. PubMed ID: 17630962 [TBL] [Abstract][Full Text] [Related]
19. Vitiligo: pathomechanisms and genetic polymorphism of susceptible genes. Shajil EM; Chatterjee S; Agrawal D; Bagchi T; Begum R Indian J Exp Biol; 2006 Jul; 44(7):526-39. PubMed ID: 16872041 [TBL] [Abstract][Full Text] [Related]
20. Short- and long-term effects of acetylsalicylic acid treatment on the proliferation and lipid peroxidation of skin cultured melanocytes of active vitiligo. Zailaie MZ Saudi Med J; 2004 Nov; 25(11):1656-63. PubMed ID: 15573197 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]